Nucleotides (NT) and nucleosides (NS) are added to infant formula to mimic the content of breast milk, but little is known about their impact on infant gut microbiota. In this study, we tested the effect of NS and of yeast extracts (YE) with different NT content using PolyFermS continuous fermentation models mimicking formula-fed, healthy and enteropathogen-contaminated infant gut microbiota. Microbiota composition, short-chain fatty acid (SCFA) formation and gene expression were determined. NS, and to a larger extend YE modulated microbiota composition and increased metabolic activity in both models. Anaerococcus, Peptoniphilus, Fusobacterium, Lactobacillus/Pediococcus/Leuconostoc and Veillonella were enhanced when YE and/or NS were added. The production of SCFA increased with the level of supplied NT equivalents. Addition of NS and YE reduced colonization of Salmonella compared to control periods. Gene expression analysis confirmed taxonomical changes and indicated functional responses to YE. Transcripts related to NT and sulfur metabolism and iron acquisition increased while biosynthesis of co-factors and vitamins decreased after YE addition. Elevated butyrate formation correlated with increased transcripts encoding key enzymes of the two major butyrate synthesis pathways. Our results uncover a strong dose-dependent modulation of NS and YE on infant gut microbiota composition and metabolic activity.
INTRODUCTION
Development of the gastrointestinal microbiota is initiated at birth, and is impacted by host genetics, natural and cultural environment, health status, delivery mode, age and diet (Matamoros et al. 2013) . Mothers' milk is the major source of nourishment for neonates after birth, which contributes to infant development and health and supports establishment of the gut microbiota (Ballard and Morrow 2013) . Major components of human milk are lactose (70 g L −1 ), lipids (40 g L −1 ), proteins (8 g L −1 ) and human milk oligosaccharides (5-15 g L −1 ) (Zivkovic et al. 2011 ).
Also present in human milk at lower concentrations are nucleic acids (∼70 μM), nucleosides (NS, ∼10 μM) and nucleotides (NT, ∼85 μM), which constitute 10%-20% of the non-protein nitrogen (Thorell, Sjoberg and Hernell 1996) . Several brands of infant formula contain NT. Pancreatic nucleases degrade nucleic acids to NTs that can be further hydrolyzed to NS by intestinal nucleotidases or alkaline phosphatases (Carver and Walker 1995) . Nucleosidases release purine and pyrimidine bases from NS. More than 90% of the bases are absorbed during transit through the upper gastrointestinal tract; nevertheless, a significant proportion of NS can reach the colon and are available to the colonic microbiota (Uauy, Quan and Gil 1994) . Many bacterial species are able to synthesize NT de novo, yet competition for NT and precursors within the gut microbiota is high as they are essential for bacterial growth and proliferation (Kilstrup et al. 2005) . Auxotrophic bacteria, such as lactic acid bacteria, require purines or pyrimidines to be added to growth medium; these molecules are then converted to NT using salvage pathways. Prototrophic bacteria can synthesize NT de novo, but preferentially take up and metabolize available nucleobases and NS using salvage pathways (Kilstrup et al. 2005) .
Few studies have investigated the impact of NT or NS in human milk and formula on infant gut microbiota composition, and results were conflicting and limited to analysis of some bacterial groups. Singhal et al. (2008) reported that fecal microbiota composition of infants fed formula supplied with NT more closely resembled fecal microbiota of breast fed infants than a control group not fed NT, which contrasted with the findings of Balmer, Hanvey and Wharton (1994) , who did not observe such a similarity. Yet, both studies agreed that NT addition can modulate gut microbiota composition.
Competition for nutrients constitutes a mechanism by which intestinal microbiota prevents colonization of certain enteric pathogens. For example, auxotrophic Salmonella mutants lost virulence in murine models of infection, likely because of purine limitation in vivo (McFarland and Stocker 1987) . However, no data exist on the impact of dietary NS or NT on infant gut microbiota contaminated with enteropathogens, though intestinal pathogen contamination is a worldwide phenomenon of infants living in poor hygienic conditions (Baltazar, Tiglao and Tempongko 1993) .
We therefore aimed to investigate how NS and NT addition impacts the composition and metabolic activity of healthy and enteropathogen-contaminated infant gut microbiota using modeling in the PolyFermS platform (Zihler Berner et al. 2013; Lacroix, de Wouters and Chassard 2015) . Two models were developed using PolyFermS. Model 1 was inoculated with immobilized fecal microbiota of a 6-month formula-fed, healthy infant, while model 2 was inoculated with immobilized fecal microbiota of a 8-month formula-fed, healthy infant that was artificially contaminated with a mix of enteropathogens to mimic gut microbiota of an infant living in rural areas of Kenya (Jaeggi et al. 2015) .
The tested NS mix was formulated based on Codex guidelines reflecting the amount of NS and nucleic acid bases delivered to the proximal colon of formula-fed infants (Carver and Walker 1995) . Yeast extract (YE) was selected as a complex source of NT and NS, and also because it contains additional bioactive components. In animal nutrition, yeast cell walls, YE or NT extracted from YE were fed to piglets to ease the dietary transition during weaning, which resulted in improved growth performance, higher feed intake and weight gain, and reduced occurrence of diarrhea (Carlson, Veum and Turk 2005; MartinezPuig et al. 2007) . Three YE products with differing equivalent NT content (NuPro, Alltech Inc., low, standard and high NT YE, LYE, SYE and HYE, respectively), as well as NS mix, were tested at different concentrations for their impact on composition and activity of the modeled colon microbiota. Metatranscriptomics was performed to investigate gene expression profiles in response to NS and YE treatments.
MATERIALS AND METHODS

Experimental set up of the Infant PolyFermS fermentation models
In this study, two different designs of in vitro continuous intestinal fermentation models based on PolyFermS were applied to mimic healthy and pathogen-contaminated microbial communities (F1 and F2, respectively, Fig. 1 ). F1 comprised a firststage inoculum reactor containing immobilized infant fecal microbiota that was used to continuously inoculate at 10% (v/v) a set of second-stage reactors, a control reactor and four test reactors, mounted in parallel (Fig. 1A) . All F1 reactors were operated at conditions prevailing in the infant proximal colon and were fed with a medium mimicking the chyme entering the colon of a formula-fed infant (Table S1 , Supporting Information).
F2 was set up to mimic infant proximal and distal colon conditions (Fig. 1B ). An inoculum reactor inoculated with immobilized fecal microbiota of a healthy infant was used to continuously inoculate (5%, v/v) two reactors mounted in parallel run at proximal colon conditions (proximal colon reactor) that were each attached to second reactors run at distal colon conditions (distal colon reactor) (Fig. 1B) . The fermentation medium composition was designed to mimic the chyme of an African infant living in poor environmental conditions and fed with a mixed diet (Jaeggi et al. 2015) (Table S1 ). The enteric pathogens Salmonella enterica ssp. enterica Typhimurium N-15, Clostridium difficile DSM 1296T, C. perfringens DSM 756 and enteropathogenic Escherichia coli (EPEC) O157:H45 were spiked once in inoculum and proximal colon reactor of F2 to approximate the natural infection levels of the African infant gut (Jaeggi et al. 2015) . Three days after initiation of continuous fermentation, 2 mL of overnight cultures of S. Typhimurium, C. difficile, Clostridium perfringens and EPEC were added at 5.0 × 10 8 , 1.5 × 10 8 , 7.6 × 10 8 and 1.0 × 10 8 gene copies mL −1 , respectively.
Control reactor of F1 and control period of F2 fed standard fermentation media without added NS or YE were used as controls for the respective supplementation treatments. IRs received standard media containing 2.5 g L −1 SYE (Table 1) based on the medium designed for formula-fed infants (Le Blay et al. 2010) to maintain microbial diversity. F1 and F2 were carried out for 40 and 18 days, respectively. Effluent samples for microbiota analysis were collected during the last three consecutive days of each treatment period corresponding to a pseudo-steady state of a treatment estimated from stable metabolite production.
Immobilization and bead fermentation procedures
Fresh fecal samples were collected under aseptic conditions from 6-(F1) and 8-(F2) month-old healthy infant girls who had not been treated with antibiotics during the past 3 months. Samples were anaerobically transported at chilled temperatures to the laboratory within 2 h after defecation. This study was not subject to review by the Ethics Committee of ETH Zurich because the fecal sample collection was done without causing harm to the infant donors and with prior verbal consent from their parents. Feces were immobilized in gel beads made of gellan gum, xanthan and sodium citrate in an anaerobic chamber as described previously (Cinquin et al. 2004) . Gel beads with diameters of 1-2 mm were anaerobically inoculated at 30% (v/v) into the inoculum reactor containing fresh medium and with total working volumes of 200 mL. Fermentation was initiated in batch mode by aseptically replacing spent medium with fresh medium every 12 h for 3-4 days. After switching to continuous operation, the inoculum reactor was fed with fresh medium at flow rates of 27 and 33 mL h −1 , corresponding to mean retention times of 7.4 and 6.1 h for F1 and F2, respectively. After 5 days, the inoculum reactor was connected to the control and test reactors in F1, and to each one of the proximal colon reactor in F2, which was in series with a distal colon reactor. Based on reported transit times of 5.4-36.5 h for 4-month-old infants (Cinquin et al. 2006) , a mean retention time of 6 h was maintained in control and test reactors of F1, and in proximal colon reactor of F2. Control and test reactors of F1 were continuously supplied with 10% (v/v) inoculum from IR, and with 90% (v/v) fresh medium for the corresponding control or treatment conditions at a flow rate of 30 mL h −1 to a fermentation volume of 180 mL. In F2, proximal colon reactors (210 mL) received 5% (v/v) inoculum from the inoculum reactor and 95% (v/v) fresh medium at a flow rate of 35 mL h −1 . Distal colon reactors (420 mL) were fed 100% with proximal colon reactor effluent at a flow rate of 35 mL h −1 , for a mean retention time of 12 h. All reactors were operated at 37
• C and 120 rpm under anaerobic conditions by continually flushing the headspace of all reactors and medium bottles with CO 2 . NaOH (2.5 M) was automatically added to maintain a pH of 6 in all reactors of F1. In F2, the pH was controlled at pH 5.8 (inoculum and proximal colon reactor) and 6.8 (distal colon reactor), according to pH ranges of 5.7-6.0 and 6.6-6.8 in the infant proximal and distal colon, respectively (Cinquin et al. 2006) .
Fermentation medium
The standard fermentation media used in F1 and F2 were modified versions of the nutritive medium previously described by Le Blay et al. (2010) that simulates the chyme entering the proximal colon of formula-fed infants (Table S1 ). The composition of the medium for F2 took into account the daily food intake of Kenyan infants aged 6-8 months, which consists of 500 mL breast milk complemented with ∼330 g uji, a fermented porridge made with maize or millet (Jaeggi et al. 2015) (Table S1 ). Before autoclaving (121 • C, 20 min), the pH of the medium was adjusted to 6 and 5.8 for F1 and F2, respectively. Filter-sterilized vitamin solutions were added to the medium immediately before use. All chemicals and reagents used in this study were obtained from SigmaAldrich, except whey protein hydrolysate (MyProtein), soy peptone (Labo-Life), KH 2 PO 4 (VWR International AG) and YE (NuPro; Alltech, Inc.).
NS and YE supplementation
Pure NS mix and three different YE products with low, standard and high NT content (LYE, SYE and HYE) that contained 6.1%, 10.6% and 23.7% NT equivalents (Table 1) , respectively, were used according to the experimental plan presented in Fig. 1C and D. The NS mix was formulated based on Codex guidelines for infant formula with NT digestibility of 10%, and reflected the amount of NS and nucleic acid bases delivered to the proximal colon of formula-fed infants (Carver and Walker 1995) . Concentrations of YE were chosen so that at the lowest concentration added, NT equivalents of the NS mix based on Codex guidelines and YE were comparable (Table 1) combinations of NS and SYE (NS50-SYE2.5 and NS50-SYE5) were tested. SYE2.5 and SYE5 were repeated in F1 (SYE2.5-2 and SYE5-2). Selected treatments, NS100, SYE5 and SYE7.5, which were shown to strongly impact microbial composition and metabolic activity in F1 were tested in F2. NS and YE were added twice daily every 12 h. Effluents were collected 6 h after NS and/or YE addition. Effluent samples and cell pellets were either quick-frozen in liquid nitrogen and stored at -80 • C or immediately processed for analysis.
Total DNA extraction and qPCR analysis
The FastDNA SPIN Kit for Soil (MP Biomedicals) was used to extract DNA from infant donor feces and from effluents. The quality and quantity of DNA were estimated by using a NanoDrop ND-1000 Spectrophotometer (Witec AG). Total bacteria and selected bacterial groups commonly found in the infant gut were enumerated by qPCR using an ABI PRISM 7500-PCR sequence detection system (Applied Biosystems). Each qPCR reaction (25 μL) contained 1 μL DNA as template, forward and reverse primers (0.2 pM final, Table S2 , Supporting Information), and 2 × SYBR Green PCR Master Mix (Applied Biosystems). Reactions were run in duplicate. Thermocycling conditions consisted of initial denaturation step at 95
• C for 10 min, followed by 40 cycles of denaturation at 95
• C for 15 s, annealing and extension at 60
• C for 1 min. Amplification specificity was confirmed by melting curve analysis. A standard curve was generated with 10-fold serial dilutions of the PCR amplicon of interest to calculate gene copies mL −1 effluent.
16S rRNA gene sequencing and analysis
Genomic DNA from infant feces and from pooled DNA samples of the last three consecutive days of each control or treatment period was used to generate amplicon libraries of the V5-V6 hypervariable regions (Dostal et al. 2015) . Barcoded pyrosequencing was conducted using a 454 Life Sciences Genome Sequencer FLX with Titanium chemistry (Roche AG) at DNAVision SA. The RDP (Ribosomal Database Project) Classifier v2.1 was used for the taxonomic identities of sequences at an 80% confidence level (Wang et al. 2007 ).
Nucleic acid isolation, RNA purification and rRNA depletion for metatranscriptomics
Nucleic acids were extracted from effluent samples obtained from control periods, NS100 and SYE7.5 treatments of F2 with a phenol-chloroform bead-beating procedure as described previously (Schwab et al. 2014) . Total RNA was extracted using the AllPrep DNA/RNA Mini Kit (Qiagen) according to the manufacturer's instructions with additional DNase treatment (Ambion). RNA integrity was analyzed using the RNA 6000 Nano Chip Kit on the Bioanalyzer 2100 (Agilent), and only samples with an RNA Integrity Number greater than 9 were further processed. MICROBExpress Bacterial mRNA Enrichment Kit (Ambion) was used for rRNA depletion from 4 μg of total RNA following the manufacturer's specifications.
Metatranscriptome sequencing and bioinformatic analysis
Paired-end RNA-seq using an Illumina HiSeq 2500 v4 was conducted at the Functional Genomics Center Zurich (ETH Zurich, Switzerland). RNA libraries were prepared using TruSeq RNA stranded library preparation kit and standard protocols supplied by Illumina. For bioinformatics analysis, a pipeline consisting of SortMeRNA for separation of rRNA and mRNA and FLASH for overlapping the paired-end sequences was used (Magoc and Salzberg 2011; Kopylova, Noe and Touzet 2012) . Putative mRNAs were compared to the NCBI RefSeq database using MALT (http://ab.inf.uni-tuebingen.de/software/malt/). Transcripts were taxonomically classified using MEGAN (Huson et al. 2007) . Putative mRNA reads were also uploaded to MG-RAST for functional classification according to the SEED Subsystem scheme using default settings (Meyer et al. 2008) . Statistically significant differences between metatranscriptomes were identified using STAMP (Parks and Beiko 2010) .
HPLC analysis with refractive index detection (HPLC-RI)
Short-chain fatty acids (SCFA), formate and lactate were analyzed in effluent samples using HPLC (Merck-Hitachi) equipped with a SecurityGuard Cartridges Carbo-H column (4 × 3 mm; Phenomenex), a Rezex ROA-Organic Acid H + column (8%, 300 × 7.8 mm; Phenomenex) and a refractive index detector (HPLC-RI). Effluents were centrifuged at 13 000 × g for 10 min at 4
• C, and supernatants were filtered prior to analysis. Samples (20 μL) were eluted with 10 mM H 2 SO 4 at a flow rate of 0.4 mL min −1 at 40 
NH 3 analysis
For detection of NH 3, frozen supernatants of fermentation effluents were diluted to concentrations within the linear range of the standard curve, and were reacted with Nessler's reagent (Fluka AG) (Streuli and Averell 1971) . Absorbance was measured using a FL600 Microplate Fluorescence Reader (Bio-Tek Instruments) set to 425 nm. For preparation of a standard curve, a dilution series of ammonium chloride was prepared in the range of 0-7.2 mg L −1 NH 4 + . All samples were analyzed in duplicate.
Statistical analysis
Statistical analysis of qPCR data and metabolite concentrations was carried out using JMP 11.0 Statistical Discovery Software (SAS Institute). Temporal stability of the fermentation models during the experiment was monitored using qPCR data, metabolite and NH 3 concentrations in effluents of the inoculum reactor of F1 and F2, using a non-parametric Kruskal-Wallis test. A nonparametric Kruskal-Wallis test was also employed for pairwise comparison of abundance of selected bacterial groups, SCFA and NH 3 concentrations between treatments and the control reactor during the treatment period (F1), or between treatments and the control period (F2). To investigate significant differences between treatments, ratios of qPCR data, SCFA and NH 3 concentrations of treatments and controls were calculated, and were subjected to one-way analysis of variance followed by the TukeyKramer-HSD test. A P-value of <0.05 was considered significant for all tests.
Nucleotide sequence accession number
The 16S rRNA sequencing data obtained in this study were submitted to the National Center 
RESULTS
PolyFermS fermentation models
To investigate the impact of NS and YE on gut microbiota composition and metabolic activity, two different PolyFermS continuous intestinal fermentation models were inoculated with immobilized fecal microbiota from two healthy infant donors and operated at different conditions. F1 was set to mimic the microbiota of the proximal colon segment of a healthy formula-fed infant, while F2 was designed to mimic enteropathogen-contaminated microbiota of the proximal and distal colon segments of an infant (Fig. 1) .
qPCR data showed that all tested enteropathogens, Salmonella Typhimurium, Clostridium difficile, C. perfringens and EPEC, stably colonized inoculum, proximal and distal colon reactors of F2 during the fermentation period (Table 2) . Generally, the concentration of enteropathogens was higher in proximal and distal colon reactors compared to the inoculum reactor, except for C. perfringens, which had similar levels. The log gene copies of C. difficile, C. perfringens and EPEC were similar in proximal and distal colon reactors, while S. Typhimurium invA copies were ∼1 log unit higher in distal colon than in proximal colon reactor.
The total and individual SCFA concentrations recorded in inoculum reactor and reactor of F1 showed a slight and steady increase during the first ca. 15 days, after which they remained constant until the end of the 40-day fermentation. SCFA concentrations were highly stable during the 18 days of F2 (Fig. S1 , Supporting Information). Total SCFA concentrations were higher in the inoculum reactor of F1 than in F2 (96.3 ± 4.3 and 71.3 ± 3.8 mM, respectively), reflecting a richer composition of the medium used to mimic the formula diet compared to the Kenyan mixed diet (Tables 3 and 4) . Acetate contributed ∼67% and 76% of the SCFA pool in F1 and F2, respectively. The proportion of propionate was slightly higher than butyrate in both fermentations (F1: 19 vs 15%, F2: 13 vs 11%). Lactate and formate were only detected in F1, while isovalerate was only present in F2 (Tables 3 and 4) .
Microbial composition in donor feces and inoculum reactors of PolyFermS models
The microbial community composition and diversity of donor feces and inoculum reactor effluents was investigated using 16S rRNA gene sequencing (Table S3 , Supporting Information). In donor feces of F1, the phyla Firmicutes (17%), Bacteroidetes (50%) and Actinobacteria (29%) contributed the majority of reads, while Proteobacteria (4%) was present in low abundance ( Fig. 2A) . Compared to donor feces, the relative abundance of Firmicutes and Fusobacteria in the reactors was more than 2-fold higher, while the abundance of Bacteroidetes was reduced. Shifts on the family level between donor and inoculum reactor were also observed (Fig. 2B) . In feces, Actinobacteria were mainly composed of Bifidobacteriaceae, whereas Coriobacteriaceae prevailed in IR. In IR, Lachnospiraceae and Prevotellaceae were major families of Firmicutes and Bacteroidetes, respectively, while Lactobacillaceae and Ruminococcaceae predominated in feces. In donor feces of F2, Actinobacteria (mainly Bifidobacteriaceae) were most abundant, while in the IR, Firmicutes and Bacteroidetes were the most prominent phyla, contributing 46% and 33% of the reads, respectively (Fig. 2C) . In the IR, Clostridiaceae, Enterococcaceae, Erysipelotrichaeceae and Clostridiales incertae sedis XIV were representative of the phylum Firmicutes, while Bacteroidaceae was the major family of the Bacteroidetes (Fig. 2D) . Proteobacteria (mainly Enterobacteriaceae) and Fusobacteria (mainly Fusobacteriaceae) accounted for ∼9% and 2% of the reads in IR, respectively.
Impact of NS and YE on microbial composition and metabolic activity in F1
Different concentrations of NS and YE with varying NT content alone and in combination were tested in test reactors (Fig. 1C) . Microbiota composition of effluent samples was determined using qPCR and 16S rRNA gene sequencing for selected samples. Treatments were compared to the control reactor, which had been fed with medium lacking YE and NS, of the corresponding treatment period (Fig. 1C) .
In effluents of control and test reactors, total bacterial populations ranged from 10.3 to 11.1 log 16S rRNA gene copies mL −1 (Table 5 ). NS addition (NS1, NS50 and NS100) increased the abundance of Firmicutes by up to 0.9 log unit and by up to 0.5 log unit of the low abundant Lactobacillus/Leuconostoc/Pediococcus, with stronger effects observed at a higher NS dosage. In contrast, NS had little impact on the other bacterial groups tested (Table 5 ). Addition of YE with different NT levels also increased abundance of Firmicutes and Lactobacillus/Leuconostoc/Pediococcus spp. in the combination treatments (NS50-SYE2.5, NS50-SYE5) in a dose-dependent manner. LYE significantly enhanced abundance of Enterobacteriaceae. In contrast, abundance of the Bacteroides-Porphyromonas-Prevotella group after any treatment was not significantly different from the control reactor, and Bifidobacterium xfp gene copies were only increased by selective treatments (Table 5) .
Effluent samples of the control reactors and from NS50, SYE5-2, SYE7.5, HYE5 and NS50-SYE5 treatment were additionally investigated using 16S rRNA gene sequencing (Table S3 , Supporting Information), as these treatments caused shifts of the microbiota measured by qPCR. Relative abundances of Prevotellaceae and Streptococcaceae were reduced after additions of NT or YE compared to the control reactor (Fig. 3A) . Supplementation of SYE7.5 increased the relative abundance of Anaerococcus, Peptoniphilus, Fusobacterium and Lactobacillus more than 3-fold compared to the control, while Lactococcus and Atopobium decreased (Fig. 3B) . The relative abundance of Bifidobacterium was only enhanced by HYE5. Veillonella, Anaerococcus and Peptoniphilus also increased after addition of NS50 alone or in the combination treatment NS50-SYE5.
In general, increasing amounts of both NT and YE produced elevated levels of total SCFA, along with decreased levels of formate (Table 3) . Production of SCFA increased up to an equivalent NT addition of 0.6-0.8 g L −1 , and reached a plateau at higher levels (Fig. 4A) . Total SCFA production was higher for YE than for NS supplementation with equivalent NT content (Fig. 4A ). NS and YE addition significantly increased NH 3 levels compared to the control reactor of the corresponding period, in a dose-dependent manner (Table 3) .
Impact of NS and YE supplementation on contaminated infant microbiota of F2
Because treatments with NS100, SYE5 and SYE7.5 induced large changes in microbiota composition and metabolic activity in F1, these treatments were selected for testing in F2 and compared to the control period that was supplied with medium lacking YE and NS (Fig. 1D) . Addition of NS100, SYE5 and SYE7.5 slightly but significantly increased 16S rRNA gene copies of total bacteria in proximal and distal colon reactors compared to the control period; Firmicutes, the Bacteroides-Porphyromonas-Prevotella group and Lactobacillus/Leuconostoc/Pediococcus spp. were significantly enhanced. Additionally, the abundance of Bifidobacterium spp. and Enterobacteriaceae were significantly higher with NS100 (Table 2 ).
Excluding YE from the feeding medium during the control period increased the concentration of S. Typhimurium, C. difficile and EPEC by 1.6, 0.9 and 1.3 log units, respectively, in proximal colon reactors compared to the inoculum reactor (Table 2) , while the abundance of C. perfringens was slightly but not significantly lower. Compared with the control period, treatments NS100 and SYE7.5 significantly decreased S. Typhimurium in the proximal colon reactor (-1.7 and -0.8 log units), while all tested treatments decreased S. Typhimurium in the distal colon reactor. qPCR data showed small or no effect of any treatment on C. difficile and EPEC abundance, except for NS100 that significantly reduced the concentration of C. difficile compared to the control. A significant (P < 0.05) stimulation of C. perfringens was observed for all tested treatments in the proximal colon reactor compared to the control period ( Table 2) .
The 16S rRNA gene sequencing data confirmed the increase in relative abundance of Bacteroidetes due to an increase of Bacteroidaceae and Prevotellaceae (Fig. 3C ). In agreement with F1, relative abundances of the genera Anaerococcus, Peptoniphilus and Fusobacterium increased when SYE7.5 was added (Fig. 3D) . Furthermore, the abundance of Veillonella increased with NS100 treatment compared to the control reactor. Treatments with NS100, SYE5 and SYE7.5 strongly enhanced SCFA production (Table 4) . Acetate production significantly increased in the NS100, SYE5 and SYE7.5 treatments compared to the control period, while only SYE7.5 significantly enhanced production of propionate and butyrate. Similar to F1, the increase in SCFA formation was dependent on the equivalent NT content of the treatments, with YE having a stronger impact than NS100 (Fig. 4B) .
Gene expression of pathogen-contaminated infant gut microbiota supplemented with NS and YE
Because supplementations with NS100 and SYE7.5 caused major shifts in microbial composition and metabolism of the pathogen-contaminated microbiota, we used metatranscriptomics to further investigate gene expression of the microbial communities after supplementation. Metatranscriptomics yielded between 225 000 and 1.57 Mio putative mRNA reads (Table S4 , Supporting Information). Putative mRNA reads were taxonomically classified using MALT (Table S5 , Supporting Information). In the proximal colon reactor during the control period, transcripts assigned to the Firmicutes prevailed, while Proteobacteria contributed almost 50% of all transcripts in the distal colon reactor. SYE7.5 supplementation decreased the relative abundance of Proteobacteria transcripts in proximal and distal colon reactor compared to the control period, confirming the decline in relative abundance observed by 16S rRNA gene sequencing and qPCR. The relative abundance of Bacteroidetes transcripts was enhanced after addition of SYE7.5, due to an increase of Prevotellaceae in particular in both in proximal and distal colon reactors, which was also observed with 16S rRNA gene sequencing. Compared to the control, supplementation with NS100 increased the relative abundance of Bifidobacteriaceae transcripts and resulted in a decrease of Erysipelotrichaceae transcripts in both proximal colon reactors. In proximal colon reactors only, the relative abundance of Bacteroidetes increased with addition of NS100. Putative mRNA reads were assigned to SEED categories using MG-RAST and statistically analyzed using STAMP (Parks and Beiko 2010) . The impact of colon segment (proximal versus distal) was larger than the impact of treatments with NS or YE (Fig. S3, Supporting Information) . In the proximal colon reactor, SEED categories 'Carbohydrates' and 'Protein metabolism' were more abundant than in distal colon reactors, whereas in distal colon reactors transcripts allocated to 'Stress Response' were increased (Table S6 , Supporting Information). SYE7.5 supplementation significantly increased the relative abundance of SEED categories 'Nucleosides and Nucleotides', 'Sulfur Metabolism' and 'Iron Acquisition and Metabolism', while the relative abundance of the category 'Cofactors, Vitamins, Prosthetic Groups, Pigments' was reduced in treated proximal and distal colon reactors compared to the control period (Fig. 5) . Applying NS100 did not significantly impact the relative abundance of any major SEED category. Within 'Nucleosides and Nucleotides', transcripts related to 'Pyrimidine Conversions' were more abundant with SYE7.5 (Table S7 , Supporting Information). SYE7.5 supplementation also enhanced the transcription of iron and hemin uptake systems of gram-negatives as well as transcripts of 'Galactosylceramide and Sulfatide metabolism'.
Because the addition of SYE7.5 in particular led to an increase in butyrate formation in both proximal and distal colon reactors compared to the control period, we investigated the relative abundance of transcripts related to butyrate production from acetyl-CoA and lysine (Fig. 6 ). In the proximal colon reactor, transcripts for butyrate formation via butyrate kinase were increased, while in distal colon reactors, transcripts for butyryl-CoA:acetate-CoA transferase and butyrateacetoacetate-CoA transferase, the final step for the formation of butyrate from acetoacetate, were enhanced. Transcripts encoding butyrate kinase (between 53 and 340 reads per treatment) were extracted from MEGAN. Reads were mainly assigned to Bacteroidales and Clostridiales (mostly Peptostreptococcaceae). In both PR and DR, the proportion of Bacteroidales butK transcripts increased from 58% to 68% and from 41% to 58% with SYE7.5, respectively, compared to the control period. Primers were designed to target Bacteroidales butK and used to quantify butK genes (Table S2 ). The abundance of butK gene copies was ∼1 log unit higher after additions of NS100 and SYE7.5 compared to the control period, indicating that the increase in abundance of transcripts was likely due to an a general increase of Bacteroidales and not due to enhanced transcription.
DISCUSSION
NT and NS reach the colon microbiota as dietary components of mother's milk and of infant formula. Nevertheless, few studies have focused on the impact of NT supplementation on infant gut microbiota (Singhal et al. 2008) . As the outcome of nutritional supplementation on gut microbiota can depend on the health status of the host, we tested NT in two different PolyFermS intestinal fermentation models mimicking a healthy infant gut (F1) and an infant gut artificially contaminated with pathogens (F2). Different forms of NT were tested, including pure NS and YE with different NT contents. Ratios of bacterial populations in model samples are frequently different from those tested in the fecal inoculum depending on model, donor and applied conditions (Payne et al. 2012) . This is inherent to modeling that use fixed conditions to mimic the host and are not mimicking the host functions. PCR and 16S rRNA gene sequencing data indicate that microbiota composition was globally well preserved between donor and fermenter.
Total SCFA formation in inoculum reactor and during the control period of F2 was lower compared to inoculum and control reactor of F1, likely due to the adaptation of the feeding medium designed to mimic a mixed diet of an infant living in Figure 6 . Impact of SYE7.5 addition on expression of transcripts related to butyrate formation in F2. Shown are the major pathways leading to butyrate from acetyl-CoA and lysine. Fold expression relative to control fermentations in proximal and distal colon reactors are indicated in blue and green, respectively.
rural Kenya (Jaeggi et al. 2015) . This medium contained lower amounts of lactose, iron and protein hydrolysates, and more complex carbohydrates, compared to F1. Nevertheless, despite differences in initial gut microbiota composition and diet, NS and YE showed similar effects on total SCFA production in both models. NS100, SYE5 and SYE7.5 increased the amount of total SCFA formed by 30%, 49% and 66% compared to the corresponding control reactor in F1, and by 17%, 42% and 68% compared to the control period in F2, respectively. In contrast, the NS1 treatment prepared according to Codex guidelines did not enhance SCFA production. The total SCFA response depended on the equivalent NT content of a YE treatment, and the form in which the NT was supplied as also previously observed (Possemiers et al. 2013) . SCFA production was higher for YE than for NS mixes with the same equivalent NT content. The YE used based on the NuPro series was derived from cytoplasmic contents of Saccharomyces cerevisae and contained a substantial proportion of protein (>50% crude protein, dry weight basis), amino acids, inositol and vitamins in addition to high NT content (Craig and McLean 2006; Fegan 2006) , thus supplying additional nutrients for metabolism by the gut microbiota.
The increase of transcripts related to metabolism of 'Nucleosides and Nucleotides', 'Sulfur metabolism' and 'Iron acquisition' suggested that YE provided sulfur and iron in addition to NT and NS, while the decrease of transcripts related to 'Cofactors, Vitamins, Prosthetic Groups, Pigments' indicated that YE reduced the need for biosynthesis of selected compounds. The rise in transcripts of galactosylceramide and sulfide metabolism, which includes transcripts encoding glycosyl hydrolases involved in the degradation of mucin, also indicates that adding YE might have increased the ability of the microbiota to degrade other glycan compounds, such as host-derived mucin that was also a component of the feeding media used.
The increase of SCFA formation with NS and YE treatment compared to the control period of F2 was mainly observed in the proximal colon reactor, suggesting that distal colon metabolism was not impacted by supplementation, and that NS and fermentable YE components were mostly metabolized in the proximal colon reactor. Gene expression analysis further revealed spatial differentiation of bacterial activity. The increased abundance of transcripts related to carbohydrate metabolism indicated the fermentation processes of complex carbohydrates occurred mainly in treated PR. Likewise, transcripts of the SEED category 'protein metabolism' were increased in treated proximal colon reactors, which includes protein biosynthesis as an indicator of growth, as well as to protein and peptide degradation.
Supplementation with NS and, even more pronounced, with YE vigorously modulated the microbial community composition in the model systems for both the healthy and pathogencontaminated infant guts. Despite major differences in microbial composition of donors and models, selected taxa reacted similarly to supplementation. The abundance of Anaerococcus spp. and Peptoniphilus spp. increased by adding NS and YE in both models. Both genera are non-saccharolytic and use peptone and amino acids as major energy sources to produce butyrate (Ezaki et al. 2001) . Also, Fusobacterium obtains its energy from amino acid metabolism (Rogers et al. 1998) . The increased abundance of frequently auxotrophic lactobacilli might be attributed to the addition of NS, NT or to other constituents of YE, such as amino acids, vitamins and minerals derived from the yeast cells.
SCFA result from trophic interactions of members of the intestinal microbiota. Here, the addition of NT and YE most strongly enhanced acetate formation, and to a lesser extent butyrate in some treatments. Clostridiales are considered major butyrate producers in the human intestine (Vital et al. 2013; Vital, Howe and Tiedje 2014) . Members of the Bacteroidetes have only rarely been reported to produce butyrate in vitro (Touw, van Steenbergen and De Graaff 1982) . Nevertheless, recent studies indicated the presence of the genetic arsenal necessary to produce butyrate (Vital et al. 2013) . Here, we observed an increase of butyrate kinase transcripts assigned to the Bacteroidetes upon addition of mainly YE that correlated with an increase in butyrate formation. Despite lacking experimental proof that the increase of butyrate was indeed due to metabolic activity of Bacteroidetes, the presence of Bacteroidetes transcripts related to butyrate formation suggests that within a complex intestinal community, Bacteroidetes might contribute to butyrate production.
Salmonella Typhimurium, and to a lesser extent Clostridium difficile, increased under nutrient-limited conditions after excluding YE from the feeding medium, consistent with observations that these enteric pathogens are thriving during malnutrition. Protein-malnourished rats were more susceptible to S. Typhimurium infection compared to control rats (Bradley and Kauffman 1988) , and Salmonella was detected in in 33% of Kenyan children living in poor rural settings (Brent et al. 2006) . Interestingly, both Salmonella and C. difficile declined following resupplementation with NS100, while only Salmonella decreased to a lesser extent with SYE7.5, suggesting that NT addition may decrease enteropathogen colonization.
In conclusion, our findings using advanced PolyFermS in vitro continuous intestinal fermentation models give first insights into the effects of dietary NS and YE containing different NT levels on the taxonomic and functional profiles of healthy and pathogen-contaminated infant gut microbiota. Supplementation with NS and YE enhanced SCFA production (primarily acetate and butyrate), the abundance of bacterial taxa capable of amino acid utilization, and decreased the abundance of Salmonella and C. difficile. YEs exerted stronger effects than NS for a similar equivalent NT content and may be a valuable dietary supplement to modulate the gut microbiota in addition to other nutritional benefits for the host. We also report here a first in vitro gut fermentation model using the PolyFermS platform to mimic a contaminated microbiota of infants living in a poor rural environment. Results obtained here set the stage for further research into applying dietary NT/NS and YE to modulate infant gut microbiota for improved gut health and nutritional status of infants.
